SEC Comment Letter 0000000000-25-002611 to IMPACT BIOMEDICAL INC. (IBO)

IMPACT BIOMEDICAL INC.
Date: March 10, 2025 · CIK: 0001834105 · Accession: 0000000000-25-002611

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-42212

Date

March 10, 2025

Author

Finance

Form

UPLOAD

Company

IMPACT BIOMEDICAL INC.

Letter

Re: Impact BioMedical, Inc. Form 10-K for the Fiscal Year Ended December 31, 2023 Filed February 20, 2024 File No. 001-42212 Dear Todd D. Macko:

March 10, 2025

Todd D. Macko Chief Financial Officer Impact BioMedical, Inc. 275 Wiregrass Pkwy West Henrietta, NY 14586

We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Sincerely,
Division of Corporation
Finance
Office of Life Sciences

Show Raw Text

<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 March 10, 2025

Todd D. Macko
Chief Financial Officer
Impact BioMedical, Inc.
275 Wiregrass Pkwy
West Henrietta, NY 14586

 Re: Impact BioMedical, Inc.
 Form 10-K for the Fiscal Year Ended December 31, 2023
 Filed February 20, 2024
 File No. 001-42212
Dear Todd D. Macko:

 We have completed our review of your filings. We remind you that the
company and
its management are responsible for the accuracy and adequacy of their
disclosures,
notwithstanding any review, comments, action or absence of action by the staff.

 Sincerely,

 Division of Corporation
Finance
 Office of Life Sciences
</TEXT>
</DOCUMENT>

SecProbe.io